Circles That Mutate

Read full text Summarise with VIRAT
Authors: Lali Latsabidze
Cited by: 0
References: 36

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Extrachromosomal circular DNA (eccDNA) and its large oncogenic counterpart, ecDNA, are pervasive yet systematically overlooked components of the somatic genome. Unlike linear chromosomes, circular DNA lacks telomeres, replicates via error-prone rolling-circle mechanisms, and segregates randomly during mitosis. These properties confer an accelerated mutational dynamics upon the circular compartment, yet standard genomic workflows—from DNA extraction and exome capture to short-read alignment and variant calling—are optimized for linear, diploid reference architectures. This review synthesizes current knowledge of circular DNA mutagenesis across five domains. First, the mutational spectrum of circular DNA is distinct from that of chromosomal DNA, enriched for microhomology-mediated indels, complex structural rearrangements, and interchromosomal chimeric fusions. Second, experimental isolation methods, including exonuclease digestion and rolling circle amplification, introduce specific biases that distort mutational discovery. Third, computational detection requires graph-based assembly, junction-aware realignment, and copy-number-normalized burden estimation to distinguish true somatic variants from amplification artifacts. Fourth, validation strategies—inverse PCR, mutation-specific FISH, and single-cell sequencing—confirm that ecDNA mutations exhibit transient inheritance yet drive sustained phenotypic effects through temporary transcriptional dominance. Fifth, the absence of a universal circular reference genome, the difficulty of discriminating replication errors from authentic mutations, and the lack of clinical standardization remain critical barriers to translation. Despite these challenges, the integration of ecDNA analysis into oncogenomic panels is urgently warranted: ecDNA amplifications are present in approximately 14% of all cancers, confer poor prognosis independent of chromosomal copy number, and serve as privileged sites for the acquisition of therapy resistance mutations. Furthermore, eccDNA mutation burden correlates with cellular age and genotoxic stress, suggesting utility as a quantitative biomarker. Emerging therapeutic strategies aim to eliminate ecDNA, disrupt its segregation, or silence its transcription, though specificity remains a major obstacle. The central conclusion is that mutations in circular DNA are not rare biological exceptions—they are rendered invisible by a genomic paradigm that equates the genome with the chromosomes. Making these mutations visible requires nothing less than a conceptual redefinition of the genome itself.

Fields of Study & Subjects

Genomic variations and chromosomal abnormalities Cancer Genomics and Diagnostics Circular RNAs in diseases

Publication details

Journal / source
Annals of Rejuvenation Science
Publication date
1 January 2026
Language
EN